CoreBone

CoreBone has developed and is distributing bioactive coral-based bone graft materials, providing a natural alternative for dental and orthopedic indications, replacing synthetic or human and animal-derived (bovine, porcine) bone graft materials. CoreBone is a portfolio company of The Trendlines Group Ltd. (SGX: 42T) (OTCQX: TRTL), supported by the Israel Innovation Authority.